News

Dr. Acheson will be an instrumental advisor for Index's BioTag-backed insurance product, which aims to increase the global capacity for product contamination & recall insurance.

The Food Traceability Final Rule (Rule 204) has major implications for stakeholders within complex supply chains. The main theme? Get ready to collect, maintain and share key product data within the next three years.

The origin of BioTags came out of a discomfort that I’ve had with our collective obsession for seamless interoperability between our organizations, the physical things that we create and their digital footprints. APIs, blockchain solutions, digital twins, and web3 (once the semantic web), among others, are all initiatives around the collective need to model and share our data with those who rely on it.

ICTC's Mairead Matthews and Faun Rice sat down with Canadian entrepreneur Remi Schmaltz to talk about his experience in successfully scaling his second business, and to hear his advice for new startups.

“We believe BioTags have the potential to almost eradicate illegal seed practices. They not only provide brands with secure on-product evidence regarding permitted use, but the mere existence of a BioTagged seed will deter malicious actors from illicit acts..."

We’ve learned a lot since launching in 2019, and today we commemorate that progress with a website refresh.

Index Biosystems (Index) announced today the formal addition of Remi Schmaltz as Vice President of Corporate Development, Prof Vincent Martin as a Scientific Advisor and Micah Siegel as a member of the Board of Directors.

Index Biosystems was approved for funding through the Sustainable Development Technology Canada (SDTC) Seed Fund. The $100K CAD investment will further product development and the commercialization of BioTags to revolutionize agri-food industry sustainability.

The inability to inextricably connect our data to our products is at the core of ESG failures, quality control risk, and international fraud.

Index Biosystems is building complete supply-chain transparency with a low-cost, scalable solution.

Index Biosystems has exceeded its financing targets on its journey to define the next generation of supply-chain traceability and anti-counterfeiting.

The innovative startup behind BioTags — a new category of in-product bio-based traceability technology — closed its seed round target of $1 million with an oversubscription to $1.5 million (all figures USD) led by Vanedge Capital, with the participation of new strategic partner CBS Bio Platforms, and Creative Destruction Lab (CDL) mentors.